Results 171 to 180 of about 73,206 (244)
Letter to the Editor: Enhancing the methodological rigor and interpretation of findings in a cross-sectional study on drinking water type and kidney stone risk in U.S. adults. [PDF]
Zhou XJ, Chen JL, Fu Y.
europepmc +1 more source
ABSTRACT Background Central nervous system (CNS) inflammatory demyelinating syndromes, including multiple sclerosis (MS), aquaporin‐4 antibody–positive neuromyelitis optica spectrum disorder (AQP4 + NMOSD), and myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD), occasionally overlap.
Bade Gulec +6 more
wiley +1 more source
Integrating knowledge graphs with ancient Chinese medicine classics: challenges and future prospects of multi-agent system convergence. [PDF]
Xiang S, Lin H, Cai F, Jiang Z.
europepmc +1 more source
ABSTRACT Background Cognitive impairment is a common non‐motor symptom in Multiple Sclerosis (MS), negatively affecting autonomy and Quality of Life (QoL). Innovative rehabilitation strategies, such as semi‐immersive virtual reality (VR) and computerized cognitive training (CCT), may offer advantages over traditional cognitive rehabilitation (TCR ...
Maria Grazia Maggio +8 more
wiley +1 more source
Inspirations of traditional Chinese martial arts Qinggong training for parkour. [PDF]
Zhang J, Zhan Y, Wu L, Liu T, Li Z.
europepmc +1 more source
ABSTRACT Background and Purpose White matter hyperintensities (WMH) are a core neuroimaging marker of cerebral small vessel disease (CSVD). Sleep apnoea (SA) is a recognized vascular risk factor, but its associations with regional WMH burden, short‐interval WMH change and cognitive performance in population‐based cohorts remain incompletely defined. We
Peng Cheng +4 more
wiley +1 more source
Advancing psychiatric care through neuromodulation: From translational research to clinical practice. [PDF]
Linden DEJ.
europepmc +1 more source
Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS
ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket +14 more
wiley +1 more source
The building as a body: architectural perspectives in anatomy and the musculoskeletal system. [PDF]
Meudic Y +3 more
europepmc +1 more source

